We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

416 hedge funds and large institutions have $5.91B invested in Charles River Laboratories in 2020 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 166 increasing their positions, 129 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 4 → 12 (+8)

164% more call options, than puts

Call options by funds: $29.6M | Put options by funds: $11.2M

29% more repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 129

11% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 56

1% more funds holding

Funds holding: 413 → 416 (+3)

2.11% less ownership

Funds ownership: 96.87% → 94.76% (-2.1%)

18% less capital invested

Capital invested by funds: $7.23B → $5.91B (-$1.32B)

Holders
416
Holders Change
+3
Holders Change %
+0.73%
% of All Funds
9.17%
Holding in Top 10
12
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+200%
% of All Funds
0.26%
New
62
Increased
166
Reduced
129
Closed
56
Calls
$29.6M
Puts
$11.2M
Net Calls
+$18.4M
Net Calls Change
-$9.11M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$61.4M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$52.9M
3
IAM
Iridian Asset Management
Connecticut
+$39.9M
4
SCM
Sandler Capital Management
New York
+$27.2M
5
CIM
Confluence Investment Management
Missouri
+$25M

Top Sellers

Rank Fund Capital Flow
1
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management
California
-$84.8M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$60.6M
3
Millennium Management
Millennium Management
New York
-$49.6M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$47.5M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$39.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
51
Federated Hermes
Pennsylvania
$28M +$7.27M +48,441 +28%
Westfield Capital Management
52
Westfield Capital Management
Massachusetts
$28M -$757K -5,046 -2%
SEI Investments
53
SEI Investments
Pennsylvania
$25.8M +$2.62M +17,468 +9%
Acadian Asset Management
54
Acadian Asset Management
Massachusetts
$24.1M -$10.1M -67,057 -26%
ACM
55
American Capital Management
New York
$24M – – –
TD Asset Management
56
TD Asset Management
Ontario, Canada
$24M +$13.1M +87,671 +86%
Victory Capital Management
57
Victory Capital Management
Texas
$23.8M +$22.9M +152,755 +429%
CCMG
58
Clark Capital Management Group
Pennsylvania
$23.8M -$160K -1,068 -0.6%
Lazard Asset Management
59
Lazard Asset Management
New York
$23.5M +$854K +5,694 +3%
SCM
60
Sandler Capital Management
New York
$22.9M +$27.2M +181,300 New
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$22.7M +$2.06M +13,712 +8%
Public Employees Retirement Association of Colorado
62
Public Employees Retirement Association of Colorado
Colorado
$21.8M -$105K -698 -0.4%
CIM
63
Confluence Investment Management
Missouri
$21M +$25M +166,366 New
RCAMU
64
Rothschild & Co Asset Management US
Connecticut
$20.9M -$2.19M -14,581 -8%
Retirement Systems of Alabama
65
Retirement Systems of Alabama
Alabama
$19.1M – – –
Principal Financial Group
66
Principal Financial Group
Iowa
$19M -$9.41M -62,722 -29%
Deutsche Bank
67
Deutsche Bank
Germany
$18.7M +$20.2M +134,647 +993%
Citadel Advisors
68
Citadel Advisors
Florida
$18.4M +$4.86M +32,398 +29%
BNP Paribas Asset Management
69
BNP Paribas Asset Management
France
$18.2M +$2.51M +16,755 +13%
Millennium Management
70
Millennium Management
New York
$17.8M -$49.6M -330,998 -70%
SCM
71
Snyder Capital Management
California
$17.2M +$3.19M +21,242 +18%
UBS AM
72
UBS AM
Illinois
$17.1M +$5.11M +34,073 +34%
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
$17M -$489K -3,261 -2%
PM
74
Pembroke Management
Quebec, Canada
$16.7M +$2.17M +14,491 +12%
PPA
75
Parametric Portfolio Associates
Washington
$15.8M +$792K +5,282 +4%
1 2
3
4 5

CRL Hedge Fund Activity: Q1 2020 in Review

416 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2020, worth a combined $5.91B — down 18% from $7.23B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new CRL positions and 56 closed out — a net gain of 6 holders — while 166 added to existing stakes and 129 trimmed.

The largest buyer was HealthCor Management, adding an estimated $61.4M. The largest seller was Kayne Anderson Rudnick Investment Management, cutting an estimated $84.8M.

  • 416 institutional investors held Charles River Laboratories (CRL) as of Q1 2020, up from 413 in Q4 2019.
  • Funds reported $5.91B of Charles River Laboratories stock for Q1 2020, down 18% quarter-over-quarter.
  • 62 funds opened new Charles River Laboratories positions in Q1 2020 and 56 closed out, a net change of +6 holders.
  • The largest Charles River Laboratories buyer in Q1 2020 was HealthCor Management, an estimated $61.4M added.
  • The largest Charles River Laboratories seller in Q1 2020 was Kayne Anderson Rudnick Investment Management, an estimated $84.8M sold.

Based on aggregated 13F filings for Q1 2020.